Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study
Paolo Corradini, Chiara Agrati, Giovanni Apolone, Alberto Mantovani, Diana Giannarelli, Vincenzo Marasco, Veronica Bordoni, Alessandra Sacchi, Giulia Matusali, Carlo Salvarani, Pier Luigi Zinzani, Renato Mantegazza, Fabrizio Tagliavini, Maria Teresa Lupo-Stanghellini, Fabio Ciceri, Silvia Damian, Antonio Uccelli, Daniela Fenoglio, Nicola Silvestris, Fausto Baldanti, Giulia Piaggio, Gennaro Ciliberto, Aldo Morrone, Franco Locatelli, Valentina Sinno, Maria Rescigno, Massimo Costantini on behalf of the VAX4FRAIL Study Group
doi: https://doi.org/10.1101/2022.01.12.22269133
Paolo Corradini
1Department of oncology and hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy
2School of Medicine, University of Milan, Italy
Chiara Agrati
3Cellular Immunology Laboratory, National Institute for Infectious Diseases L Spallanzani – IRCCS, Rome, Italy
Giovanni Apolone
4Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy
Alberto Mantovani
5Humanitas Scientific Directorate, IRCCS Humanitas, Clinical and Research Center, Rozzano, Italy
6Department of Biomedical Sciences, Humanitas University, Milan, Italy,
7William Harvey Research Institute, Queen Mary University, London, United Kingdom,
Diana Giannarelli
8Biostatistical Unit, Istituto Nazionale Tumori Regina Elena IRCCS - IFO, Rome, Italy
Vincenzo Marasco
1Department of oncology and hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy
2School of Medicine, University of Milan, Italy
Veronica Bordoni
3Cellular Immunology Laboratory, National Institute for Infectious Diseases L Spallanzani – IRCCS, Rome, Italy
Alessandra Sacchi
3Cellular Immunology Laboratory, National Institute for Infectious Diseases L Spallanzani – IRCCS, Rome, Italy
Giulia Matusali
9Virology Laboratory, National Institute for Infectious Diseases L Spallanzani – IRCCS, Rome, Italy
Carlo Salvarani
10Unità di Reumatologia, Azienda USL-IRCCS, Reggio Emilia, Italy
11Unità di Reumatologia, Università degli Studi di Modena e Reggio Emilia, Modena
Pier Luigi Zinzani
12Istituto di Ematologia “Seràgnoli”, Azienda Ospedaliero-Universitaria di Bologna - IRCCS, Bologna, Italy
13Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy
Renato Mantegazza
14Neuromuscular Diseases and Neuroimmunology Unit, Fondazione IRCCS Isitituto Neurologico Carlo Besta, Milano, Italy
Fabrizio Tagliavini
15Scientific Directorate, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
Maria Teresa Lupo-Stanghellini
16Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy
Fabio Ciceri
17Scientific Directorate, IRCSS San Raffaele Scientific Institute, Milano, Italy
Silvia Damian
1Department of oncology and hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy
Antonio Uccelli
18Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health and Center of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, Italy,
19Biotherapy Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy
Daniela Fenoglio
19Biotherapy Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy
20Centre of Excellence for Biomedical Research and Department of Internal Medicine, University of Genoa, Italy
Nicola Silvestris
21Medical Oncology Department, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy
22Department of Biomedical Sciences and Human Oncology, University of Bari “Aldo Moro”, Bari, Italy
Fausto Baldanti
23Molecular Virology Unit, Fondazione IRCCS Policlinico San Matteo
24Department of Clinical, Surgical, Diagnostics and Pediatric Sciences, University of Pavia, Pavia, Italy
Giulia Piaggio
25SAFU Unit IRCCS Regina Elena, National Cancer Institute, Istituti Fisioterapici Ospitalieri (IFO), Rome, Italy
Gennaro Ciliberto
26Scientific Directorate IRCCS Regina Elena, National Cancer Institute, Istituti Fisioterapici Ospitalieri (IFO), Rome, Italy
Aldo Morrone
27Scientific Directorate, San Gallicano Dermatological Institute IRCCS, Rome, Italy
Franco Locatelli
28Department of Pediatric Hematology and Oncology and Cell and Gene Therapy, IRCCS Ospedale Pediatrico Bambino Gesù
29Department of Gynecology-Obstetrics and Pediatrics, University “La Sapienza”, Roma, Italy
Valentina Sinno
1Department of oncology and hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy
Maria Rescigno
6Department of Biomedical Sciences, Humanitas University, Milan, Italy,
30Mucosal Immunology and Microbiota Unit, IRCCS Humanitas Clinical and Research Center, Milano, Italy
Massimo Costantini
31Scientific Directorate, Azienda Unita Sanitaria Locale (USL)-IRCCS Reggio Emilia, Reggio Emilia, Italy
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted January 13, 2022.
Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study
Paolo Corradini, Chiara Agrati, Giovanni Apolone, Alberto Mantovani, Diana Giannarelli, Vincenzo Marasco, Veronica Bordoni, Alessandra Sacchi, Giulia Matusali, Carlo Salvarani, Pier Luigi Zinzani, Renato Mantegazza, Fabrizio Tagliavini, Maria Teresa Lupo-Stanghellini, Fabio Ciceri, Silvia Damian, Antonio Uccelli, Daniela Fenoglio, Nicola Silvestris, Fausto Baldanti, Giulia Piaggio, Gennaro Ciliberto, Aldo Morrone, Franco Locatelli, Valentina Sinno, Maria Rescigno, Massimo Costantini
medRxiv 2022.01.12.22269133; doi: https://doi.org/10.1101/2022.01.12.22269133
Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study
Paolo Corradini, Chiara Agrati, Giovanni Apolone, Alberto Mantovani, Diana Giannarelli, Vincenzo Marasco, Veronica Bordoni, Alessandra Sacchi, Giulia Matusali, Carlo Salvarani, Pier Luigi Zinzani, Renato Mantegazza, Fabrizio Tagliavini, Maria Teresa Lupo-Stanghellini, Fabio Ciceri, Silvia Damian, Antonio Uccelli, Daniela Fenoglio, Nicola Silvestris, Fausto Baldanti, Giulia Piaggio, Gennaro Ciliberto, Aldo Morrone, Franco Locatelli, Valentina Sinno, Maria Rescigno, Massimo Costantini
medRxiv 2022.01.12.22269133; doi: https://doi.org/10.1101/2022.01.12.22269133
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2841)
- Dermatology (243)
- Emergency Medicine (428)
- Epidemiology (12551)
- Forensic Medicine (10)
- Gastroenterology (803)
- Genetic and Genomic Medicine (4425)
- Geriatric Medicine (401)
- Health Economics (715)
- Health Informatics (2849)
- Health Policy (1047)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4184)
- Nursing (222)
- Nutrition (617)
- Oncology (2200)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (267)
- Palliative Medicine (81)
- Pathology (486)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6775)
- Radiology and Imaging (1487)
- Respiratory Medicine (899)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (174)